These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2897813)

  • 1. Hemodynamic effects of nebivolol in men: comparison of radionuclide angiocardiography with systolic time intervals.
    De Crée J; Franken P; Vandevivere J; Geukens H; Verhaegen H
    Angiology; 1988 Jun; 39(6):526-34. PubMed ID: 2897813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute hemodynamic effects of nebivolol in man at rest and during exercise.
    De Crée J; Geukens H; Cobo C; Verhaegen H
    Angiology; 1987 Jun; 38(6):440-8. PubMed ID: 2884904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J; Cobo C; Geukens H; Verhaegen H
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
    De Cree J; Van Nueten L; Geukens H; Verhaegen H
    Int J Clin Pharmacol Res; 1992; 12(4):159-63. PubMed ID: 1363660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antihypertensive and cardiac hemodynamic effects of nebivolol.
    DeCrée J; Van Rooy P; Geukens H; Haeverans K; Verhaegen H
    Angiology; 1992 May; 43(5):369-77. PubMed ID: 1348916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
    Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
    J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of nebivolol on the cardiovascular hemodynamics during postural changes and isometric exercise.
    Duprez D; Lefebvre R; De Backer T; De Sutter P; Trouerbach J; Clement DL
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):709-17. PubMed ID: 1679662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
    Stoleru L; Wijns W; van Eyll C; Bouvy T; Van Nueten L; Pouleur H
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure.
    Brune S; Schmidt T; Tebbe U; Kreuzer H
    Angiology; 1990 Sep; 41(9 Pt 1):696-701. PubMed ID: 1977335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
    Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
    Van de Water A; Janssens W; Van Neuten J; Xhonneux R; De Cree J; Verhaegen H; Reneman RS; Janssen PA
    J Cardiovasc Pharmacol; 1988 May; 11(5):552-63. PubMed ID: 2455841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency].
    Boutelant S; Lechat P; Komajda M; Isnard R; Salloum J; Gagey S; Bertholon JF; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):863-70. PubMed ID: 1358044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study.
    Brehm BR; Wolf SC; Görner S; Buck-Müller N; Risler T
    Eur J Heart Fail; 2002 Dec; 4(6):757-63. PubMed ID: 12453547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of nebivolol.
    Janssens WJ
    J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
    Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
    Ignarro LJ
    Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
    Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
    Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.